Hyposensitization Preseason

Preseasonal hyposensitization (PSH) is a form of immunotherapy used to reduce allergy symptoms in patients suffering from seasonal allergies.

GPP is carried out in the period before the season of dusting allergens such as pollen, plant resin and dust. Before preseason hyposensitization begins, the patient's sensitivity to allergens is assessed by blood tests or skin tests. In addition, the patient must be fed anti-allergenic food several days before the start of the program, and also receive appropriate treatment for allergic diseases on a regular basis.

During the process of hyposensitization, the pre-season patient is examined for allergens and a course of doses is administered to the body. During HPT, patients typically take antihistamines for at least two weeks before and after the intervention. This helps prevent allergic reaction attacks. Hyposensitizing pre-season drugs can be injectable or tablet. Typically, doctors use minimal starting doses to minimize possible side effects. In most cases, GPP is continued for at least two months to achieve optimal effectiveness.

To achieve optimal results, GPP is often combined with other forms of therapy, including topical application and environmental management.

Hyposensitizing preseason treatment (G.).

This is a therapeutic agent that fights asthma. The disease is characterized by attacks of shortness of breath and worsening breathing in dry weather. In spring, autumn or summer, it is recommended to begin and complete the prevention of an attack upon contact with a potential pathogen.